Myelodysplastic Syndrome
News
Red-cell donor’s sex does not affect transfusion survival
New study showed that the sex of a red blood cell donor has no bearing on the survival of the transfusion recipient.
News
New hope for MDS, with AML treatments
Slow progress in treating myelodysplastic syndrome is coming mostly with therapies first developed for acute myeloid leukemia.
News
VEXAS syndrome: More common, variable, and severe than expected
A large U.S. analysis found that this newly discovered genetic disease has a estimated prevalence of 1 in 4,269 in men older than 50.
Conference Coverage
‘Extremely exciting’ study results guide MM treatment options
New trial data help inform the tailoring of effective treatment approaches for patients with newly diagnosed multiple myeloma (MM).
Conference Coverage
Myeloid patients respond robustly to Moderna COVID vaccine
Among 46 patients, nearly all seroconverted after second shot.
Conference Coverage
For leukemias, COVID-19 death risks tied to poor prognoses, ICU deferrals
COVID-19 death risks for acute leukemias were driven by poor physician-assessed prognoses and opting out of recommended ICU care.
News
Extended virus shedding after COVID-19 in some patients with cancer
Some patients, including stem cell transplant and CAR T recipients, may require extended periods of isolation.
Conference Coverage
In MDS, transplant ups survival in elderly and may be reimbursed
News
ASH tackles COVID-19 with hematology-related FAQ, promotes new registries